New National Guideline

Description of impact

Based on my research the British Society for Antimicrobial Chemotherapy have published a new national guideline for the assessment of children with possible invasive meningococcal disease.

Who is affected

All children with fever and a non-blanching rash in the UK

Narrative

The Petechiae in Children study was the largest ever study of fever and non-blanching rashes performed. Including over 1300 children from 37 UK hospitals it represents the best evidence for the management of this high risk group. The findings from this research have been translated into new national guidance. This will impact thousands of children every year. It will result in fewer children having their meningococcal infection missed. It will also result in fewer admissions to hospital and better antimicrobial stewardship.

Impact status	Completed
Impact date	30 Sept 2016
Category of impact	Health Impact
Impact level	Adoption